Legislation roundup: Data security, pharma antitrust and insurance investment in REITs

November 19, 2021 | BY

Susan Mok

Data processors may not take biometric features as the sole method of authenticating individuals' identities. Anti-monopoly guidelines are set forth regarding the active pharmaceutical ingredient sector. Insurance capital may invest in REITs.

Cybersecurity

Cyberspace Administration of China, Regulations for the Administration of Cyber Data Security (Draft for Comments)

国家互联网信息办公室网络数据安全管理条例 (征求意见稿)

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]